Skip to content
PreclinicalResearch compoundLimited evidence

Lemairamin

Zanthoxylum-derived α7 nicotinic agonist; anti-inflammatory neuroprotectant, preclinical only.

NootropicCholinergicCholinergicMemoryAcetylcholinenoo.affects.neuroprotectionnoo.affects.anti-inflammatory

Pharmacology

ClassCholinergic · Memory
Primary targetAlpha-7 nicotinic acetylcholine receptor agonism
Targets4 receptor targets
Half-lifeNo human pharmacokinetic data
OnsetNo reliable human data (studies typically assume daytime dosing)
EvidenceLimited evidence
Affected systemsAcetylcholinenoo.affects.neuroprotectionnoo.affects.anti-inflammatory

Contents

WHAT IS LEMAIRAMIN?

Detailed overview

Lemairamin (also called Wgx-50 or gx-50) is a protoalkaloid amide isolated from the pericarp of Sichuan pepper (Zanthoxylum species), identified as an agonist of the alpha-7 nicotinic acetylcholine receptor. By activating the alpha-7 nAChR it engages both cognitive signaling and the cholinergic anti-inflammatory pathway: it suppresses microglial inflammatory activation, lowers pro-inflammatory cytokines, and acts as a neuroprotectant through the JAK2/STAT3 and PI3K/AKT pathways. In preclinical models it reduced pain sensitivity, attenuated beta-amyloid accumulation and improved cognitive readouts in Alzheimer's models. There are essentially no human clinical trials: human pharmacokinetics and safety are uncharacterized, so it exists only as an experimental natural-product compound.

Mechanism

Alpha-7 nAChR agonist + anti-inflammatory

Evidence

Preclinical only (no human data)

Origin

Zanthoxylum (Sichuan pepper) protoalkaloid

Receptor profile

  • Alpha-7 nicotinic acetylcholine receptorsStrong
  • JAK2/STAT3 and PI3K/AKT anti-inflammatory signalingModerate
  • Beta-amyloid aggregation / channels (inhibition)Moderate
  • Microglia-mediated neuroinflammation (suppression)Moderate

Safety

Side effects, stop signs, contraindications

Side effects · 4

  • No human safety data: evidence comes only from preclinical (rodent, zebrafish and in silico) studies
  • Theoretical cholinergic overstimulation (nausea, sweating, increased gut motility) at high doses
  • Unknown long-term safety and uncharacterized toxicity profile in humans
  • Possible gastrointestinal irritation or allergic reaction typical of Zanthoxylum extracts

Contraindications · 3

  • Pregnancy and breastfeeding: safety not established, avoid
  • Known allergy to Zanthoxylum (Sichuan pepper) or related spice plants
  • Not an approved medicine; experimental compound, not recommended without clinical supervision

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Zanthoxylum-derived α7 nicotinic agonist; anti-inflammatory neuroprotectant, preclinical only.

Telegram

Have a question about Lemairamin?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC19H21NO3
UpdatedJuly 10, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: July 10, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.